missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ MAP3K7/MAP3K7IP1 (TAK1-TAB1) Recombinant Human Protein
Fusion of MAP3K7 to MAP3K7IP1 (TAB1) activates MAP3K7.
Marke: Invitrogen™ PR8004B
Weitere Details : Netto-Gewicht : 0.01000kg
Beschreibung
MAP3K7 (TAK1) controls transcription regulation and apoptosis, and is implicated in inflammatory disease and rheumatoid arthritis.
Spezifikation
| NP_663306, NP_006107 | |
| 50mM Tris pH 7.5, 150mM NaCl, 0.5mM EDTA, 0.02% Triton X-100, 2mM DTT, 50% Glycerol | |
| 100μg | |
| RUO - research use only | |
| MAP3K7/MAP3K7IP1 (TAK1-TAB1) | |
| Human | |
| His Tag | |
| Frozen |
| Enzyme and Protein Activity Assay, Kinase Assay, Protein Assays and Analysis, Protein Biology | |
| 45.8kDa | |
| Store at -80°C. At first use, aliquot and store at -80°C to avoid multiple freeze-thaws. | |
| Full Length | |
| MLK Kinase Family | |
| Recombinant | |
| Baculovirus |